Impact Covid-19 Analysis On Sterile Injectables Market by Manufacturers to Expand 2021 | Baxter International Inc., AstraZeneca plc, Merck & Co., Inc, Novartis AG, Johnson & Johnson Services, Inc., Gilead Sciences, Inc
Moreover, in July 2016, Claris Lifescience Ltd., a sterile injectables company received the Abbreviated New Drug Application (ANDA) approval in U.S. for Tobramycin Injection USP, 80mg/2ml, and 1200mg/ 30ml multiple dose vials. Increasing demand for sterile injectables has motivated the manufacturers to expand their offering of sterile injectables, for which manufacturers are focusing to expand their sterile injectables market by opening new manufacturing facilities.
For instance, in July 2019, Mapi Pharma Ltd., an integrated, late-stage clinical development biopharmaceutical company, has entered into a lease agreement at the Har-Hotzvim Hi-Tech Park in Jerusalem for establishing a new sterile production plant for Glatiramer Acetate (GA) depot long action injectable.
Apply Promo Code “STAYHOME” and Get Up to 30% Discount
Buy This Complete A Business Report:
Key players in the market are focused on adopting inorganic growth strategies such as acquisitions, in order to expand their portfolio of sterile injectables. For instance, in July 2017, Baxter International Inc., a global medical product company acquired Claris injectables Ltd., a wholly owned subsidiary of Claris Lifesciences Ltd, a global generic injectables pharmaceutical company. Through this acquisition both the companies Baxter and Claris Injectables will provide access to lower-cost generic injectables and will help Baxter to meet the unmet needs of healthcare providers and patients around the world.
Moreover, in July 2019, Civica Rx, a hospital-owned nonprofit generic drug company, entered into a five-year agreement with Hikma Pharmaceuticals to manufacture and supply 14 sterile injectables medications. These 14 sterile injectables include general injectables used by hospitals and in emergency care, or used in surgery, pain management, and to treat hypertension.
Key takeaways of the Global Sterile Injectables Market:
The global sterile injectables market is expected to exhibit a CAGR of 7.3% during the forecast period (2019–2027), owing to increasing product launches, product approvals and mergers and acquisitions of sterile injectable companies
Increasing demand of generic sterile injectables due to high availability of products at affordable cost by manufacturers for the treatment of chronic diseases is expected to drive the global sterile injectables market growth over the forecast period.
High global prevalence of cancer, diabetes type 2, cardiovascular disease, and infectious diseases such as tuberculosis and malaria are the major therapeutic applications for sterile injectables, which is expected to drive market growth over the forecast period.
For instance, according to National Cancer Institute in 2012, around 14.1 million new cases reported of cancer and 8.2 million deaths sue to cancer observed worldwide.
Some of the major players operating in the global sterile injectables market include Baxter Inc., AstraZeneca Plc, Merck & Co. Inc, Novartis AG, Johnson & Johnson Services, Inc., Gilead Sciences, Inc., JHP Pharmaceuticals, Pfizer Inc., Fresenius Kabi Ag, CordenPharma, and Hikma Pharmaceuticals PLC.
Get PDF Brochure Of This Research Report @
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Covid-19 Analysis On Sterile Injectables Market by Manufacturers to Expand 2021 | Baxter International Inc., AstraZeneca plc, Merck & Co., Inc, Novartis AG, Johnson & Johnson Services, Inc., Gilead Sciences, Inc here
News-ID: 2246160 • Views: 1833
More Releases from business news
Impact Covid-19 Analysis On Cleanroom Consumables Market is Booming Growth
Consumables for the cleanroom are very important, which are used for the maintenance of healthy and controlled environment and also enhances the safety and efficiency of in workflow of healthcare professionals and workers. Moreover, contamination of products can be avoided using consumables by the operator and staff working by covering hair, hand, and shoes. Cleanroom consumables such as cleanroom apparels, gloves are majorly used in the manufacturing companies such as
Impact Covid-19 Analysis On Swab Market in-Depth Analysis 2021
CMI announced that it’s published an exclusive report namely Global Swab Market by Manufacturers, Regions, Type, and Application, Forecast to 2027 in its research database with report summary, table of content, research methodologies, and data sources. The research study offers a substantial knowledge platform for entrants and investors as well as veteran companies, manufacturers functioning in the Worldwide Swab Market. This is an informative study covering the market with an
Impact of COVID-19 Anaylsis On I.V. Dressing Market Size, Hampering Growth 2021
I.V. is used for delivery of medication and fluid, blood transfusions, and others in patients. It is used in patients for fluid replacement, to maintain electrolyte balance, or in patients with physical debility, and unconscious patients. I.V. dressing offers quick fixation dressing to secure I.V. Cannula, intramuscular catheters, and other percutaneous devices to the skin. I.V. dressing are transparent or translucent dressing made of adhesive material, and polyurethane collated films,
Impact of Covid-19 Analysis On Fall Detection Systems Market Strategies to Expan …
A fall detection system is a device that is used to alert emergency services in the event of a fall. Such devices have the potential to mitigate some of the adverse consequences of a fall. The global fall detection systems market is estimated to account for US$ 402.8 Mn in terms of value in 2019 and is expected to account for US$ 604.3 Mn by the end of 2027. Increasing geriatric population
More Releases for Injectables
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
Global Facial Injectables Market Forecast to 2025
eSherpa Market Reports added a new market research report on 'Global Facial Injectables Market, 2020-2025' to its database of market research collaterals consisting of complete market scenario with prevailing and future growth prospects, among other growth strategies used by important players to stay ahead of the game. Additionally, recent trends, mergers, and acquisitions, region-wise growth analysis along with challenges that are affecting the growth of the market are also stated
Psoriatic Arthritis Treatment Market 2028 | Orals, Injectables
Global Psoriatic Arthritis Treatment Market: Overview The demand within the global psoriatic arthritis treatment market has been rising on account of advancements in the field of healthcare and biosimilar analysis. The occurrence of psoriatic arthritis can place an extremely negative toll on the overall health of individuals. This is because psoriatic arthritis is more severe than any other form of arthritis. Under psoriatic arthritis, patients suffering from a skin condition
Facial Injectables Market : Enhanced longevity of the effects to augment demand …
The North America facial injectables market features a largely monopolistic landscape with only one company holding dominating share. Transparency Market Research (TMR) notes that Allergan Plc. accounts for a lion’s share of 62.0% in the market. The dominant stronghold the company has in the market derives its strength from its robust brand value of its facial injectable offering such as Juvederm and Botox (Botulinum toxin). The Botox is anticipated to
Sterile Injectables: Opportunities Galore for Generics Manufacturers
Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide. According to Piramal, the development and manufacturing of sterile injectables is highly complex and capital intensive. The operative cost for injectable is high as almost all injectables in present pharma market are toxic
Facial Injectables Market to Remain Lucrative During 2020
According to the research report, states that developing at a steady CAGR of 14.60% from 2014 to 2020, the global facial injectables market is projected to grow from a value of US$3.3 bn in 2013 to US$9.4 bn by 2020. The market for facial injectables is also driven by the rising geriatric population, growing preference for minimally invasive procedures, and increasing longevity of the effects of facial injectable products. While